Rhinology
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions
The ERS-ISIAN 2025 symposium, featuring Prof. Vibeke Backer and Prof. Sietze Reitsma, titled "Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions," will delve into the complexities of the role of type 2 inflammation in CRSwNP.
DMSc, MD
Vibeke Backer +1 more
Related resources
Learning objectives
- Understand the link between type 2 inflammation and disease severity and relapse of disease in patients with CRSwNP
- Review and critique existing criteria for defining and measuring disease control in CRSwNP, including the role of patient-reported control
- Examine phase 3, ITC, and H2H evidence of approved biologic efficacy and safety for patients with severe/uncontrolled CRSwNP
- Discuss strategies for developing internationally validated measures of CRSwNP severity and control
Description
Prof. Vibeke Backer and Prof. Sietze Reitsma will contribute their insights on future directions, including emerging therapies, personalized medicine approaches, and innovative strategies aimed at achieving better disease control and improved patient outcomes in CRSwNP.
Tags
MAT-GLB-2504853 - 1.0 - 08/2025
About these experts
